The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

TransCode Therapeutics Inc. (NASDAQ: RNAZ)

Investment Considerations Lead candidate TTX-MC138 is advancing through a Phase I/II clinical trial for metastatic cancers, targeting the critical miR-10b biomarker. Proprietary TTX platform addresses a long-standing delivery bottleneck in RNA-based oncology drug development. Strategic collaborations with institutions like Massachusetts General Hospital and MD Anderson Cancer Center validate scientific rigor. Early human data demonstrates effective … Continue reading “TransCode Therapeutics Inc. (NASDAQ: RNAZ)”

View Profile

TransCode Therapeutics Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo